tiprankstipranks
Advertisement
Advertisement

Fischer Medical Ventures Publishes SEBI-Compliant Notice on Transfer of Securities

Story Highlights
  • Fischer Medical Ventures published notices on a requested transfer of securities by investor Anil Kedia.
  • The company’s advertisements, issued under updated SEBI rules, invite claims and highlight its focus on regulatory compliance and transparency.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Fischer Medical Ventures Publishes SEBI-Compliant Notice on Transfer of Securities

Meet Samuel – Your Personal Investing Prophet

Fischer Medical Ventures Ltd ( (IN:FISCHER) ) has issued an announcement.

Fischer Medical Ventures Limited has notified the stock exchanges that it has published newspaper advertisements regarding a request received from an investor, Mr. Anil Kedia, for the transfer of securities. The advertisements, released in the English daily Financial Express and the Telugu daily Vishalandra, invite any claims from interested parties within a stipulated period, in line with SEBI’s regulatory requirements on transfer of securities. This action underscores the company’s adherence to updated SEBI circulars and disclosure norms, reinforcing its compliance posture and transparency towards shareholders and market regulators.

More about Fischer Medical Ventures Ltd

Fischer Medical Ventures Limited operates in the medical and healthcare technology sector, with its registered office located in the AP Medtech Zone in Visakhapatnam and a corporate office in Chennai, indicating a focus on medical ventures and related products or services within India’s growing medtech ecosystem.

Average Trading Volume: 262,202

Technical Sentiment Signal: Hold

Current Market Cap: 27B INR

Find detailed analytics on FISCHER stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1